Skip to main content

Advanced Wound Care Market Size worth USD 15.92 Billion by 2028, Exhibiting a CAGR of 5.7%

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Advanced Wound Care Market Research Report Are Smith & Nephew , 3M , MiMedx , Coloplast Corp , ConvaTec Inc. , Tissue Regenix , Derma Sciences Inc. , Mölnlycke Health Care AB , Organogenesis Inc., Integra LifeSciences (New Jersey, U.S.) , Other Players

Pune, India, Jan. 25, 2022 (GLOBE NEWSWIRE) — The global advanced wound care market size is anticipated to grow from USD 10.84 billion in 2021 to reach USD 15.92 billion by 2028, exhibiting a CAGR of 5.7% during the forecast period. Rising surgical procedures globally and the emergence of active wound care therapies are expected to propel the market growth. Fortune Business Insights™ provides this information in its report titled “Advanced Wound Care Market, 2021-2028.” The market stood at USD 10.03 billion in 2020.

Industry Development

  • January 2020: ConvaTec Group PLC launched its new superabsorber wound dressing solution, ConvaMax. This product was designed to manage high exuding wounds such as diabetic foot ulcers, pressure ulcers, leg ulcers, and others. 


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/advanced-wound-care-market-100060


Presence of Feasible Medical Reimbursement Policies to Boost Growth in North America

North America is projected to dominate the advanced wound care market share due to the presence of feasible medical reimbursement policies in Canada and the U.S. The market in North America stood at USD 4.15 billion in 2020 and is projected to rise substantially during the forecast period. Further, the increasing prevalence of acute and chronic wounds and high treatment costs may fuel the product demand. As per the Agency for Healthcare Research and Quality estimations, the medical pressure ulcer management ranges from USD 9.1 to USD 11.6 billion annually. These factors may boost industry development. 

In Europe, increasing awareness regarding advanced wound care advantages and robust demand for wound care devices are expected to fuel product sales. In addition, increased medical spending may lead to the growth of the market. 

In Asia Pacific, rising per-capita income and significant investment by major players are expected to fuel advanced wound care solutions’ adoption. In addition, rapid development of medical facilities in emerging economies may propel the market growth. 


To get to know more about the short-term and long-term impact of COVID-19 on this market,

Please Visit: https://www.fortunebusinessinsights.com/industry-reports/advanced-wound-care-market-100060


Segmentation

By product, the market is segmented into active wound care, wound care devices, and advanced wound dressings. As per indication, it is classified into surgical wounds, pressure ulcers, diabetic foot ulcers, and others. Based on the end-user, it is categorized into home care settings, clinics, hospitals, and others. Geographically, it is studied across Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage

The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the key players of the market.


Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/advanced-wound-care-market-100060


Prominent Companies Launch Novel Products to Boost Brand Image

The prominent companies operating in the market launch novel products to satisfy consumer demand and boost their brand image. For example, in September 2020, MIMEDX announced a placental tissue allograft, EpiCord Expandable. The product’s innovative design enables healthcare providers to cover double the surface and cater to patient’s advanced wound care demands in regards to hard-to-heal, chronic, and huge wounds.

This strategy may enable the company to satisfy consumer demand and boost its brand image. Further, the adoption of research and development may enable companies to launch innovative products that satisfy an extensive range of wound care solutions. This strategy may enable companies to boost their sales and strengthen market footing. 


Quick Buy – Advanced Wound Care Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/100060


List of Key Market Players Profiled in the Market Report:

  • Smith & Nephew (London, U.K.)
  • 3M (Minnesota, U.S.)
  • MiMedx (Marietta, Georgia)
  • Coloplast Corp (Humlebaek, Denmark)
  • ConvaTec Inc. (England, U.K.)
  • Tissue Regenix (West Yorkshire, U.S.)
  • Derma Sciences Inc. (New Jersey, U.S.)
  • Mölnlycke Health Care AB (Gothenburg, Sweden)
  • Organogenesis Inc. (Massachusetts, U.S.)
  • Integra LifeSciences (New Jersey, U.S.)


Table of Contents

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Key Indications, By Key Countries, 2020
    • New Product Launch, By Key Players
    • Key Industry Developments – Mergers, Acquisition and Partnership
    • Impact of COVID-19 on Advanced Wound Care

Toc Continue..


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/customization/advanced-wound-care-market-100060


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.